C. Bush

发表

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

M. Boguniewicz, R. Langley, L. Eichenfield, 2002, Journal of the American Academy of Dermatology.

Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.

V. Ho, F. Vanaclocha, R. Kaufmann, 2003, The Journal of pediatrics.

Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA‐HF study)

M. Burch, C. Canter, R. Shaddy, 2017, American heart journal.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

Piotr Ponikowski, Gerasimos Filippatos, Elaine Unemori, 2013, The Lancet.

Abstract 2491: Neurohumoral Effects Of A New Oral Direct Renin Inhibitor In Stable Heart Failure: The Aliskiren Observation Of Heart Failure Treatment Study (ALOFT).

S. Solomon, J. McMurray, B. Pitt, 2007 .

Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis.

A. Satlin, M. Weir, D. Keefe, 2007, Journal of the American Society of Hypertension : JASH.

The RELAXin in Acute Heart Failure (RELAX-AHF) Trial

P. Ponikowski, G. Filippatos, G. Felker, 2012 .

Influence of Body Weight and Gender on the Pharmacokinetics, Pharmacodynamics, and Antihypertensive Efficacy of Aliskiren

W. Dole, D. Howard, C. Yeh, 2010, Journal of clinical pharmacology.

Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study

P. Palatini, E. Shlyakhto, J. Botha, 2010, Journal of Human Hypertension.

Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.

J. Fowler, P. Cruz, R. Langley, 2004, Cutis.

Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

P. Ponikowski, G. Filippatos, G. Felker, 2013, Journal of the American College of Cardiology.

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies

M. Weir, A. Gradman, D. Keefe, 2010, Journal of Human Hypertension.

Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial

M. Gorostidi, R. Schmieder, T. Philipp, 2009, Journal of hypertension.